BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2909045)

  • 1. Sialyl Lewis-Xi antigen in patients with gynecologic tumors.
    Inoue M; Shimizu C; Sasagawa T; Shimizu H; Saito J; Tanizawa O
    Obstet Gynecol; 1989 Jan; 73(1):79-83. PubMed ID: 2909045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of sialyl Tn antigen in patients with gynecologic tumors.
    Inoue M; Ogawa H; Nakanishi K; Tanizawa O; Karino K; Endo J
    Obstet Gynecol; 1990 Jun; 75(6):1032-6. PubMed ID: 2342728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The clinical significance of serum sialyl Tn antigen levels in patients with gynecologic tumors].
    Shimizu C; Inoue M; Ogawa H; Ueda G; Tanizawa O
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Nov; 42(11):1537-42. PubMed ID: 2273309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical usefulness of sialyl SSEA-1 antigen as tumor marker for ovarian cancer as compared with CA125, CA19-9, TPA, IAP, CEA and ferritin.
    Yabushita H; Sawaguchi K; Hieda S; Ogawa A; Tomatsu A; Noguchi M; Ishihara M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):217-24. PubMed ID: 2566639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tissue polypeptide antigen as a tumor marker for gynecologic malignancies].
    Inoue M; Fujita Y; Abe Y; Inoue Y; Ueda G; Tanizawa O; Minagawa J; Yamada T; Ohashi K; Ozaki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1799-805. PubMed ID: 4056529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for 2----6 sialyl Lewis a antigen--2. Evaluation of clinical significance].
    Imura H; Takahashi T; Matsuda T; Yoshida O; Ohkura H; Seitetsu Y; Seino Y; Ishii M; Kuwabara M; Ariyoshi Y
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2203-12. PubMed ID: 2660749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of preoperative serum sialyl Lewis X-i antigen levels in non-small cell lung cancer.
    Satoh H; Ishikawa H; Yamashita YT; Takahashi H; Ishikawa S; Kamma H; Ohtsuka M; Hasegawa S
    Anticancer Res; 1998; 18(4B):2865-8. PubMed ID: 9713476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical evaluation of sialyl Lewis Xi antigen in patients with gynecologic tumors].
    Shimizu C; Inoue M; Sasagawa T; Shimizu H; Ueda G; Tanizawa O
    Nihon Gan Chiryo Gakkai Shi; 1989 Jul; 24(7):1393-8. PubMed ID: 2572654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum sialyl lewis X-i antigen levels in non-small cell lung cancer: correlation with distant metastasis and survival.
    Satoh H; Ishikawa H; Kamma H; Yamashita YT; Takahashi H; Ohtsuka M; Hasegawa S
    Clin Cancer Res; 1997 Apr; 3(4):495-9. PubMed ID: 9815711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinical significance of tissue polypeptide antigen (TPA) in the patients with gynecologic tumor].
    Inoue M; Inoue Y; Hiramatsu K; Tanaka Y; Yamasaki M; Ueda G; Minagawa J; Ozaki M; Yanagida T; Nishino H
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 May; 36(5):779-84. PubMed ID: 6736725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of squamous cell carcinoma antigen (SCC-A) in Egyptian gynecologic cancer patients.
    Salman T; el-Ahmady O; Tony O; Darwish M
    Anticancer Res; 1997; 17(4B):3083-6. PubMed ID: 9329607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A diagnostic evaluation of serum human telomerase reverse transcriptase mRNA as a novel tumor marker for gynecologic malignancies.
    Miura N; Kanamori Y; Takahashi M; Sato R; Tsukamoto T; Takahashi S; Harada T; Sano A; Shomori K; Harada T; Kigawa J; Ito H; Terakawa N; Hasegawa J; Shiota G
    Oncol Rep; 2007 Mar; 17(3):541-8. PubMed ID: 17273731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of monoclonal antibody OC 125 in gynecological oncology].
    Wu AR; Wang EY; Wang XX; Jia XH; Li L
    Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):132-6. PubMed ID: 3208653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
    Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M
    Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum level of sialyl Lewis(x) antigen in blood from the tumor drainage vein in patients with non-polypoid growth type of colorectal cancer.
    Nakagoe T; Sawai T; Tsuji T; Jibiki M; Ohbatake M; Nanashima A; Yamaguchi H; Kurosaki N; Yasutake T; Ayabe H; Arisawa K
    J Exp Clin Cancer Res; 2001 Mar; 20(1):85-90. PubMed ID: 11370835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sialyl Lewisa expression as a predictor of the prognosis of colon carcinoma patients in a prospective randomized clinical trial.
    Matsui T; Kojima H; Suzuki H; Hamajima H; Nakazato H; Ito K; Nakao A; Sakamoto J
    Jpn J Clin Oncol; 2004 Oct; 34(10):588-93. PubMed ID: 15591456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of 2-6 sialyl Le(a) antigen assay as a tumor marker].
    Kannagi R; Itai S; Harada R
    Nihon Rinsho; 1990 Feb; 48 Suppl():1045-52. PubMed ID: 2355503
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens expression levels as predictors of recurrence after curative surgery in node-negative colorectal cancer patients.
    Nakagoe T; Fukushima K; Tanaka K; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K
    J Exp Clin Cancer Res; 2002 Mar; 21(1):107-13. PubMed ID: 12071515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for sialyl Tn antigen: (1). Evaluation of assay conditions and normal values. STN Study Group].
    Imura H; Mori T; Ohkura H; Ishii M; Ariyoshi H; Endo J; Kitao M; Takeda I; Kobayashi H; Inoue M
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3213-9. PubMed ID: 2782915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A fundamental and clinical investigation of cancer antigen 130 (CA 130) in the field of obstetrics and gynecology].
    Inaba N; Okajima Y; Ota Y; Fukazawa I; Yamaguchi T; Sato N; Sudo H; Milanga M; Takamizawa H; Fujii S
    Nihon Gan Chiryo Gakkai Shi; 1989 Oct; 24(10):2426-35. PubMed ID: 2614181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.